VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2019 | Updates from the ZUMA-8 trial: KTE-X19 for R/R CLL

Ian Flinn, MD, PhD, from Tennessee Oncology, Nashville, TN, discusses the ZUMA-8 trial (NCT03624036) looking at KTE-X19 for R/R chronic lymphocytic leukemia (CLL). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter